YTHDF3 divergent transcript (YTHDF3-DT)

YTHDF3 divergent transcript (YTHDF3-DT) is annotated as a long non-coding RNA (lncRNA) gene located near the YTHDF3 coding gene locus[3]. Long non-coding RNAs are RNA molecules greater than 200 nucleotides in length that do not encode a protein product. The specific functions, biological pathways, and disease associations of YTHDF3-DT lncRNA have not been characterized in the biomedical literature. Most functional studies and therapeutic explorations target the protein-coding gene YTHDF3, which encodes a reader of N6-methyladenosine (m^6^A) RNA modifications and is involved in mRNA translation and decay[1][2][4]. The divergent transcript itself does not meet criteria as a canonical therapeutic target (e.g., receptor, enzyme, transporter, or protein-coding gene). The term "YTHDF3 divergent transcript" (YTHDF3-DT) is a formal lncRNA gene annotation near the YTHDF3 locus but is not widely recognized, studied, or targeted in the context of drug discovery, disease biology, or molecular pharmacology. Its functional role, regulation, and clinical implications are unknown, so it should not be conflated with the YTHDF3 protein, a well-studied m^6^A reader with described biological functions in RNA metabolism[1][2][4]. If your intent was to refer to the protein YTHDF3, that is a distinct entity with a well-characterized role as an *m^6^A reader*, while "YTHDF3-DT" is only an annotated RNA transcript with uncertain function and no established drug targeting potential or disease involvement[3].

Other names

YTHDF3-DT

None known